Skip to content

A Single-Center Exploratory Randomized Controlled Study of Fecal Microbiota transplantation for Cancer Cachexia.

A Single-Center Exploratory Randomized Controlled Study of Fecal Microbiota transplantation for Cancer Cachexia.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035014
Enrollment
Unknown
Registered
2020-07-27
Start date
2020-08-05
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer cachexia

Interventions

experimental group:Fecal microbiota transplantion

Sponsors

Changzhou NO.2 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patient is 18-70 years old and has no gender limitation. 2. The patient has no standard treatment for advanced malignant tumor. 3. The patient has cancer cachexia or at risk of malutrition. 4. Patients must sign an informed consent form and must be willing and able to comply with the visit, treatment plan, laboratory examination and other requirements of the research schedule.

Exclusion criteria

Exclusion criteria: 1. Severe depression, anxiety and other mental disorders; 2. Presence of systemic infectious diseases; 3. Obstruction; 4. Antibiotics were used within 3 weeks; 5. At the same time, participate in another interventional clinical study, unless you participate in an observational (non-interventional) clinical study or are in the follow-up phase of an interventional study; 6. Patients with uncontrolled clinical symptoms or diseases of the heart, such as: (1) NYHA grade II or above heart failure; (2) Unstable angina; (3) Myocardial infarction occurred within one year; (4) Patients with clinically significant supraventricular or ventricular arrhythmias requiring clinical intervention; 7. The fertile male or female is unwilling to take contraceptive measures in the test, and the female patient is pregnant or lactating; 8. According to the researcher's judgment, there are other factors that may cause him / her to be forced to terminate the study midway, such as other serious diseases (including mental diseases) requiring combined treatment, family or social factors, which may affect the safety of the subject or the collection of experimental data.

Design outcomes

Primary

MeasureTime frame
microbiota abundance;cytokines;immune cell;life quality;

Countries

China

Contacts

Public ContactJiang Hua

Changzhou NO.2 People's Hospital

czeyjh@njmu.edu.cn+86 18015852711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026